← Back
$GRTX All transactions

Galera Therapeutics, Inc.

C

$ Value

Shares

1,180,611

Price

Filed

Apr 9

Insider

Name

CHANG NANCY T

Title

CIK

0001135041

Roles

Director 10% Owner

Transaction Details

Transaction Date

2026-04-07

Code

C

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

8,825,543

Footnotes

On February 12, 2026, the Issuer filed a Certificate of Amendment (the "Amendment") to the Certificate of Designation of Preferences, Rights, and Limitations of Series B Non-Voting Convertible Preferred Stock. The Amendment provided that, in the sole discretion of the Issuer's board of directors, the Issuer may elect to convert, in whole or in part, outstanding shares of Series B Non-Voting Convertible Preferred Stock ("Series B Preferred Stock") into a number of shares of Common Stock calculated based on the Conversion Ratio (defined as 1,000 shares of Common Stock issuable upon the conversion of each share of Series B Preferred Stock) (a "Mandatory Conversion"). On April 7, 2026, the Issuer effected a partial Mandatory Conversion of Series B Preferred Stock, including shares of Series B Preferred Stock held by the Reporting Person. The shares of Series B Preferred Stock have no expiration date.

Filing Info

Accession No.

0000905148-26-001622

Form Type

4

Issuer CIK

0001563577

CHANG NANCY T's History

Date Ticker Type Value
2026-04-07 GRTX C
2026-04-07 GRTX C $0
2025-11-21 IMMX A $0
2025-06-03 WTI M
2025-06-03 WTI A $0
2025-06-03 WTI M $0

Other Insiders at GRTX (90d)

Insider Bought Sold Last
CHANG NANCY T 2026-04-07
FRIEDMAN MICHAEL R. 2026-04-07